Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFYA logo AFYA
Upturn stock ratingUpturn stock rating
AFYA logo

Afya Ltd (AFYA)

Upturn stock ratingUpturn stock rating
$15.67
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/15/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

9 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $19.4

1 Year Target Price $19.4

Analysts Price Target For last 52 week
$19.4 Target price
52w Low $13.47
Current$15.67
52w High $19.9

Analysis of Past Performance

Type Stock
Historic Profit -40.99%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.42B USD
Price to earnings Ratio 11.14
1Y Target Price 19.4
Price to earnings Ratio 11.14
1Y Target Price 19.4
Volume (30-day avg) 9
Beta 0.57
52 Weeks Range 13.47 - 19.90
Updated Date 09/15/2025
52 Weeks Range 13.47 - 19.90
Updated Date 09/15/2025
Dividends yield (FY) 1.49%
Basic EPS (TTM) 1.4

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 19.58%
Operating Margin (TTM) 31.02%

Management Effectiveness

Return on Assets (TTM) 8.42%
Return on Equity (TTM) 16.45%

Valuation

Trailing PE 11.14
Forward PE 8.1
Enterprise Value 1810989086
Price to Sales(TTM) 0.4
Enterprise Value 1810989086
Price to Sales(TTM) 0.4
Enterprise Value to Revenue 2.75
Enterprise Value to EBITDA 6.29
Shares Outstanding 47008300
Shares Floating 8007715
Shares Outstanding 47008300
Shares Floating 8007715
Percent Insiders 68.11
Percent Institutions 19.48

ai summary icon Upturn AI SWOT

Afya Ltd

stock logo

Company Overview

overview logo History and Background

Afya Ltd. was founded in 2019, through the combination of NRE Educacional S.A. and Medcel, both focused on medical education. It has grown through acquisitions and organic expansion to become a leading medical education group in Brazil.

business area logo Core Business Areas

  • Undergraduate Medical Education: Offers undergraduate medical degree programs across various campuses in Brazil.
  • Continuing Medical Education: Provides continuing medical education courses and resources for practicing physicians.
  • Digital Health Services: Operates digital health platforms and services connecting doctors and patients.

leadership logo Leadership and Structure

Afya's leadership team consists of experienced professionals in education, healthcare, and technology. The organizational structure is designed to support decentralized operations while maintaining central oversight and strategic direction. Renato Diniz is currently the CEO.

Top Products and Market Share

overview logo Key Offerings

  • Undergraduate Medical Degree Programs: Core offering generating significant revenue. It has high growth rates based on the current need for doctors in Brazil. Competitors include other Brazilian medical schools such as Estu00e1cio and UNIP.
  • Medcel: Medcel offers preparatory courses for medical residency exams. Competitors include Sanar and other smaller prep course providers. Specific market share data not readily available but is a leading provider in Brazil.
  • Pequeno Mu00e9dico: Pequeno Mu00e9dico is a platform to assist medical education. The number of users and revenue are not explicitly stated. Competitors include Whitebook.

Market Dynamics

industry overview logo Industry Overview

The Brazilian medical education market is growing due to a shortage of doctors and increasing demand for quality healthcare services. Government regulations and accreditation processes play a significant role in the industry.

Positioning

Afya is a leading player in the Brazilian medical education market, distinguished by its scale, comprehensive offerings, and digital capabilities. Their competitive advantages include a strong brand, a large student base, and a focus on innovation.

Total Addressable Market (TAM)

The TAM for medical education in Brazil is estimated in the billions of USD. Afya is well-positioned to capture a significant portion of this market through organic growth and acquisitions.

Upturn SWOT Analysis

Strengths

  • Leading market position in Brazilian medical education
  • Comprehensive range of medical education programs
  • Strong brand recognition
  • Focus on innovation and digital solutions
  • Experienced management team

Weaknesses

  • Exposure to regulatory changes in Brazil
  • Dependence on Brazilian economy
  • Competition from other medical education providers
  • Currency risk (BRL/USD)

Opportunities

  • Expanding into new geographic regions within Brazil
  • Acquiring complementary businesses
  • Developing new digital health services
  • Increasing online learning offerings
  • Partnerships with hospitals and healthcare providers

Threats

  • Increased competition from existing and new players
  • Changes in government regulations impacting medical education
  • Economic downturn in Brazil
  • Fluctuations in currency exchange rates

Competitors and Market Share

competitor logo Key Competitors

  • YDUQS (YDUQ3.SA)
  • Cogna Educau00e7u00e3o (COGN3.SA)

Competitive Landscape

Afyau2019s competitive advantages include a focus on medical education, strong brand, and digital capabilities. Disadvantages include exposure to the Brazilian economy and regulatory environment.

Major Acquisitions

IPEduc

  • Year: 2020
  • Acquisition Price (USD millions): 25
  • Strategic Rationale: Expanding the company's presence in specific medical specializations.

Growth Trajectory and Initiatives

Historical Growth: Afya has experienced rapid growth through acquisitions and organic expansion, capitalizing on the demand for medical education in Brazil.

Future Projections: Analyst projections often forecast continued revenue growth and profitability improvements driven by increasing enrollment and expansion into new markets.

Recent Initiatives: Recent initiatives include strategic acquisitions of medical schools and digital health companies, as well as the launch of new online learning programs.

Summary

Afya Ltd is a leading medical education group in Brazil with a strong position in a growing market. The company's focus on innovation and digital solutions, as well as its strategic acquisitions, has fueled its growth. Key challenges include exposure to the Brazilian economy and regulatory changes, which must be considered. However, overall Afya is a strong player in this education market.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Analyst Reports
  • Market Research Reports

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market share data is approximate. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Afya Ltd

Exchange NASDAQ
Headquaters Nova Lima, MG, Brazil
IPO Launch date 2019-07-19
CEO -
Sector Consumer Defensive
Industry Education & Training Services
Full time employees -
Full time employees -

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.